ICD Code | Description |
---|---|
Y740 | Diagnostic and monitoring general hospital and personal-use devices associated with adverse incidents |
Y741 | Therapeutic (nonsurgical) and rehabilitative general hospital and personal-use devices associated with adverse incidents |
Y742 | Prosthetic and other implants, materials and accessory general hospital and personal-use devices associated with adverse incidents |
Y743 | Surgical instruments, materials and general hospital and personal-use devices (including sutures) associated with adverse incidents |
Y748 | Miscellaneous general hospital and personal-use devices associated with adverse incidents, not elsewhere classified |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Y741 | Therapeutic (nonsurgical) and rehabilitative general hospital and personal-use devices associated with adverse incidents | 8.72 | NA | ||||||||||||||||
Y742 | Prosthetic and other implants, materials and accessory general hospital and personal-use devices associated with adverse incidents | 4.0 | NA |